Last update 20 Mar 2025

Human coagulation factor VIII (Nanyue Bio)

Overview

Basic Info

Drug Type
Non-recombinant coagulation factor
Synonyms-
Target
F10
Action
stimulants
Mechanism
F10 stimulants(Coagulation factor X stimulants)
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Hemophilia A
Inactive Indication-
Originator Organization
Nanyue Biopharmaceutical Co., Ltd.Nanyue Biopharmaceutical Co., Ltd.
Active Organization
Nanyue Biopharmaceutical Co., Ltd.Nanyue Biopharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (30 Apr 2021),
Hemophilia A
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Human coagulation factor VIII (Nanyue Bio)
CTR20171602
/ CompletedPhase 3
评价人凝血因子Ⅷ治疗甲型血友病（因子Ⅷ缺乏症）有效性及安全性的单臂开放性、多中心临床研究
[Translation] A single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of human coagulation factor VIII in the treatment of hemophilia A (factor VIII deficiency)
100 Clinical Results associated with Human coagulation factor VIII (Nanyue Bio)
Login to view more data
100 Translational Medicine associated with Human coagulation factor VIII (Nanyue Bio)
Login to view more data
100 Patents (Medical) associated with Human coagulation factor VIII (Nanyue Bio)
Login to view more data
100 Deals associated with Human coagulation factor VIII (Nanyue Bio)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia A
China
Nanyue Biopharmaceutical Co., Ltd.Nanyue Biopharmaceutical Co., Ltd.
30 Apr 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free